Crossmark

Immunogenomics in personalized cancer treatments

Published Online: 2021-06-30

Published Print: 2021-09

Authors

Kiyotani, Kazuma https://orcid.org/0000-0002-9236-9061
Toyoshima, Yujiro

Nakamura, Yusuke
Funding

Funding for this research was provided by:

MEXT | Japan Society for the Promotion of Science (19H03522)

Japan Agency for Medical Research and Development (17ck0106364h0003)

Japan Agency for Medical Research and Development (20ck0106543h0001)
License Information

Text and Data Mining valid from 2021-06-30

Version of Record valid from 2021-06-30
More Information

Article History

Received: 22 March 2021

Revised: 29 May 2021

Accepted: 9 June 2021

First Online: 30 June 2021

Competing interests

: KK is a scientific advisor of Cancer Precision Medicine, Inc. YN is a stockholder and a scientific advisor of OncoTherapy Science, Inc.

Document is current